1 Audia S,Mahévas M,Samson M,et al.Pathogenesis of immune thrombocytopenia[J]. Autoimmun Rev,2017,16(6):620-32. 2 Kashiwagi H,Tomiyama Y.Pathophysiology and management of primary immune thrombocytopenia[J]. Int J Hematol,2013,98(1):24-33. 3 Ji XB,Zhang LP,Peng J,et al.T cell immune abnormalities in immune thrombocytopenia[J]. J Hematol Oncol,2014,7(1):72. 4 Qu M M,Liu X N,Liu X G,et al.Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia[J]. Cytokine,2017,92:110-117. 5 Gorczynaki R M.CD200:CD200R-Mediated Regulation of Immunity[J]. ISRN Immunol,2012,2012:1-18. 6 Ren Y,Yang B,Yin YF,et al.Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation,chemotaxis and osteoclastogenesis in rheumatoid arthritis[J]. Rheumatology(Oxford,England),2015,54(4):712-721. 7 Li Y,Zhao L D,Tong L S,et al.Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity[J]. Arthritis Res Ther,2012,14(3):R123. 8 中华医学会血液学分会止血与血栓学组. 成人原发免疫性血小板减少症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志,2016,37(2):89-93. 9 Lambert M P,Gernaheimer T B.Clinical updates in adult immune thrombocytopenia[J]. Blood,2017,129(21):2829-2835. 10 Liu X,Hou Y,Peng J.Advances in immunopatho-genesis of adult immune thrombocytopenia[J]. Frontiers of Medicine,2013,7(4):418-424. 11 Qian B H,Ye X,Zhang L,et al.Increased miR-155 expression in peripheral blood mononuclear cells of primary immune thrombocytopenia patients was correlated with serum cytokine profiles[J]. Acta Haematol,2015,133(3):257-263. 12 Simelyte E,Criado G,Essex D,et al.CD200-Fc,a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis[J]. Arthritis Rheum,2008,58(4):1038-1043. 13 Simelyte E,Alzabin S,Boudakov I,et al.CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response[J]. Clin Exp Immunol,2010,162(1):163-168. |